BioXcel Therapeutics Inc (FRA:BX2)

€ 0.5724 0.0254 (4.64%) Market Cap: 25.17 Mil Enterprise Value: 68.70 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

BioXcel Therapeutics Inc at UBS Global Healthcare Conference Transcript

May 23, 2022 / 02:00PM GMT

Release Date Price: €12.7 (+2.79%)

Transcript

Colin Nigel Bristow

UBS Investment Bank, Research Division - Analyst

Good morning, everyone, and thanks for coming to the UBS Global Healthcare Conference. I'm Colin Bristow, one of the biotech analysts here. And it's my pleasure to have the BioXcel team with us. On my right, I have Vimal Mehta, Founder and CEO of BioXcel. Also from the team, we have Matt Wiley and Vince O'Neill.

Vimal, I know you have some opening statements, and congratulations on the recent approval launch. So I'll let you kick it off.

Vimal D. Mehta

BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director

Thank you, Colin, good morning, everyone. BioXcel Therapeutics is a biopharmaceutical company, developing innovative medicines in neuroscience and immuno-oncology using AI-based approach. Our 2 lead products are BXCL501, which is for acute treatment of agitation and BXCL701, which is an innate immunity activator. So those are our 2 lead products. We are very excited that this has been a very transformative year for the company, considering that we got the FDA

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.